Nadia Amrani
Associate Director, Genome Editing @Excision Biotherapeutics
Signup · Get unlimited contacts
WORK HISTORY
Associate Director, Genome Editing @Excision Biotherapeutics
Watertown, MA, US
In my role as Associate Director at Excision BioTherapeutics, I spearheaded the development of CRISPR-based therapeutics for HSV-1 and HSV-2, leading the program through pre-IND and IND-enabling studies. I managed laboratory operations, designed assays, and coordinated in vivo efficacy studies, contributing to the advancement of cutting-edge treatments.
EDUCATION
ENSAT
Master's degree, Biotechnology and Plant Breeding
Pierre and Marie Curie University
Doctor of Philosophy - PhD, Microbiology and Molecular Genetics
University of Sciences Cadi Ayad, Marrakech, Morocco
Bachelor of Applied Science - BASc, Biology, General
ABOUT NADIA AMRANI
As Associate Director at Excision BioTherapeutics, I contribute to advancing innovative therapies targeting infectious diseases by leveraging over ten years of expertise in genome editing, CRISPR technologies, and molecular biology. Collaborating with multidisciplinary teams, we develop novel approaches to address critical biomedical challenges using cutting-edge methods such as base and prime editing, protein engineering, and next-generation sequencing. My career spans extensive research in RNA biology, microscopy, and microbiology, underscoring a commitment to scientific excellence and impactful solutions. With a proven track record in multi-group project management and high-impact publications, I prioritize teamwork, analytical precision, and delivering measurable outcomes. My mission is to drive transformative applications in gene therapy, ensuring meaningful advancements in healthcare.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.